Evidence Level
Preliminary
Forskolin has a strong mechanistic rationale (direct cAMP elevation → lipolysis) but very limited clinical evidence. The Godard trial is the primary positive study, showing impressive body composition changes in overweight men. A study in women (Henderson et al., 2005) found no significant fat loss. The evidence base is too small to make confident recommendations, but the mechanism is well-understood and the safety profile is good.